AI-Driven Multi-Omics Integration for Precision Medicine in Complex Disease Diagnosis and Treatment
O.S. Bakare
Abstract
Advancements in artificial intelligence (AI) have revolutionized the integration and analysis of multi-omics data, offering unprecedented insights into precision medicine.Multi-omics, encompassing genomics, transcriptomics, proteomics, epigenomics, and metabolomics, provides a holistic view of complex biological systems.However, the sheer volume and complexity of this data pose significant analytical challenges.AI-driven approaches, including machine learning and deep learning, are uniquely equipped to address these challenges by identifying intricate patterns, uncovering disease biomarkers, and predicting therapeutic outcomes.From a broader perspective, AI integration in multi-omics has accelerated the understanding of complex diseases such as cancer, neurodegenerative disorders, and autoimmune conditions.By correlating diverse omics layers, AI enables the identification of disease subtypes, stratifying patients for targeted interventions and improving diagnostic accuracy.Furthermore, AI models enhance drug discovery by predicting compound efficacy and toxicity based on integrated omics profiles.Narrowing the focus, the application of AI in real-time multi-omics analysis is transforming clinical decision-making.Personalized treatment plans are now feasible, driven by patient-specific molecular profiles.For instance, in oncology, AI-powered tools are optimizing immunotherapy strategies by predicting patient responses to checkpoint inhibitors.Moreover, AI facilitates dynamic monitoring of disease progression, enabling timely adjustments to therapeutic regimens.Despite its transformative potential, challenges such as data heterogeneity, model interpretability, and ethical considerations remain.Addressing these issues through collaborative efforts in research, policy, and technology development will be crucial for scaling AI-driven multi-omics in precision medicine.This paradigm shift promises to redefine healthcare by enabling accurate, personalized, and proactive disease management.